I agree that this site is using cookies. You can find further informations here.
X
Gisslinger, Heinz
214  results:
Search for persons X
?
1

Renal outcome in multiple myeloma patients with cast nephro..:

Rüsing, Lina Z. ; Kozakowski, Nicolas ; Jeryczynski, Georg...
Hematology.  29 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

Event-free survival in patients with polycythemia vera trea..:

Gisslinger, Heinz ; Klade, Christoph ; Georgiev, Pencho...
Leukemia.  37 (2023)  10 - p. 2129-2132 , 2023
Link: https://doi.org/10.1038/..
 
?
3

P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPO..:

Gisslinger, Heinz ; Klade, Christoph ; Georgiev, Pencho...
HemaSphere.  7 (2023)  S3 - p. e216416f , 2023
Link: https://doi.org/10.1097/..
 
?
4

Phenotypic characterization of disease‐initiating stem cell..:

Ivanov, Daniel ; Milosevic Feenstra, Jelena D. ; Sadovnik, Irina...
American Journal of Hematology.  98 (2023)  5 - p. 770-783 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Survival expectation after thrombosis and overt-myelofibros..:

Carobbio, Alessandra ; Vannucchi, Alessandro Maria ; Rumi, Elisa...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

Change in Polycythemia Vera Treatment: Ropeginterferon Alfa..:

Gisslinger, Heinz
Turkish Journal of Hematology.  40 (2023)  4 - p. 266-268 , 2023
Link: https://doi.org/10.4274/..
 
?
7

Ruxolitinib in patients with polycythemia vera resistant an..:

Theocharides, Alexandre ; Gisslinger, Heinz ; De Stefano, Valerio...
European Journal of Haematology.  , 2023
Link: https://doi.org/10.1111/..
 
?
8

P-223 Pomalidomide (P) in relapsed/refractory multiple myel..:

Lechner-Radner, Daniel ; Greil, Richard ; Krauth, Maria-Theresa...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S158 , 2023
Link: https://doi.org/10.1016/..
 
?
9

The impact of thrombosis on probabilities of death and dise..:

Barbui, Tiziano ; Carobbio, Alessandra ; Thiele, Juergen...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
10

PD‐L1 overexpression correlates with JAK2‐V617F mutational ..:

Milosevic Feenstra, Jelena D. ; Jäger, Roland ; Schischlik, Fiorella...
American Journal of Hematology.  97 (2022)  4 - p. 390-400 , 2022
Link: https://doi.org/10.1002/..
 
?
11

Long-term outcomes of polycythemia vera patients treated wi..:

Kiladjian, Jean-Jacques ; Klade, Christoph ; Georgiev, Pencho...
Leukemia.  36 (2022)  5 - p. 1408-1411 , 2022
Link: https://doi.org/10.1038/..
 
?
12

Efficacy and safety of ruxolitinib in patients with myelofi..:

Guglielmelli, Paola ; Kiladjian, Jean-Jacques ; Vannucchi, Alessandro M....
Therapeutic Advances in Hematology.  13 (2022)  - p. 204062072211184 , 2022
Link: https://doi.org/10.1177/..
 
?
13

The cancer survival index—A prognostic score integrating ps..:

Gaiger, Alexander ; Lubowitzki, Simone ; Krammer, Katharina...
Cancer Medicine.  11 (2022)  18 - p. 3387-3396 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Inflammation-Based Scores as a Common Tool for Prognostic A..:

Arfsten, Henrike ; Cho, Anna ; Prausmüller, Suriya...
Frontiers in Cardiovascular Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Correction: Efficacy and safety of a novel dosing strategy ..:

Cervantes, Francisco ; Ross, David M. ; Radinoff, Atanas...
Leukemia.  35 (2021)  12 - p. 3626-3626 , 2021
Link: https://doi.org/10.1038/..
 
1-15